HC Wainwright Reaffirms Buy Rating for Gossamer Bio (NASDAQ:GOSS)
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright also issued estimates for Gossamer Bio’s FY2028 earnings at $0.24 EPS and FY2029 earnings at $0.55 EPS. […]
Gossamer Bio (NASDAQ:GOSS – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright also issued estimates for Gossamer Bio’s FY2028 earnings at $0.24 EPS and FY2029 earnings at $0.55 EPS. […]
